Multicentre observational study of the Gatekeeper™ for faecal incontinence

被引:26
作者
Ratto, C. [1 ]
Buntzen, S. [4 ]
Aigner, F. [5 ,6 ]
Altomare, D. F. [2 ]
Heydari, A. [3 ]
Donisi, L. [1 ]
Lundby, L. [4 ]
Parello, A. [1 ]
机构
[1] Catholic Univ, Dept Surg Sci, Proctol Unit, Largo A Gemelli 8, I-00165 Rome, Italy
[2] Univ Bari, Gen Surg Unit, Dept Emergency & Organ Transplantat, Bari, Italy
[3] Nuovo Osped Civile St Agostino Estense, Dept Gen Surg, Modena, Italy
[4] Aarhus Univ Hosp, Dept Surg P, DK-8000 Aarhus, Denmark
[5] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria
[6] Charite, Dept Gen Visceral & Transplant Surg, Campus Virchow Klinikum, D-13353 Berlin, Germany
关键词
INJECTABLE SILICONE BIOMATERIAL; ANAL-SPHINCTER DYSFUNCTION; STABILIZED HYALURONIC-ACID; LONG-TERM EFFICACY; BULKING AGENTS; INJECTION; MANAGEMENT; IMPLANTS; DEXTRANOMER; COLLAGEN;
D O I
10.1002/bjs.10050
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: A variety of therapeutic approaches are available for faecal incontinence. Implantation of Gatekeeper T prostheses is a new promising option. The primary endpoint of this prospective observational multicentre study was to assess the clinical efficacy of Gatekeeper T implantation in patients with faecal incontinence. Secondary endpoints included the assessment of patients' quality of life, and the feasibility and safety of implantation. Methods: Patients with faecal incontinence, with either intact sphincters or internal anal sphincter lesions extending for less than 60 degrees of the anal circumference, were selected. Intersphincteric implantation of six prostheses was performed. At baseline, and 1, 3 and 12months after implantation, the number of faecal incontinence episodes, Cleveland Clinic Faecal Incontinence, Vaizey and American Medical Systems, Faecal Incontinence Quality of Life Scale and Short Form 36 Health Survey scores were recorded. Endoanal ultrasonography was performed at baseline and follow-up. Results: Fifty-four patients were implanted. After Gatekeeper T implantation, incontinence to gas, liquid and solid stool improved significantly, soiling was reduced, and ability to defer defaecation enhanced. All faecal incontinence severity scores were significantly reduced, and patients' quality of life improved. At 12 months, 30 patients (56 per cent) showed at least 75 per cent improvement in all faecal incontinence parameters, and seven (13 per cent) became fully continent. In three patients a single prosthesis was extruded during surgery, but was replaced immediately. After implantation, prosthesis dislodgement occurred in three patients; no replacement was required. Conclusion: Anal implantation of the Gatekeeper T in patients with faecal incontinence was effective and safe. Clinical benefits were sustained at 1-year follow-up. The copyright line for this article was changed on 7th January 2016 after original online publication.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 30 条
[1]  
American Medical Systems (AMS), 1996, FEC INC SCOR SYST
[2]   Injectable silicone biomaterial (PTQ™) to treat fecal incontinence after hemorrhoidectomy [J].
Chan, MKY ;
Tjandra, JJ .
DISEASES OF THE COLON & RECTUM, 2006, 49 (04) :433-439
[3]   Preliminary evaluation of an injectable anal sphincter bulking agent (Durasphere) in the management of faecal incontinence [J].
Davis, K ;
Kumar, D ;
Poloniecki, J .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (02) :237-243
[4]   Evaluation of the use of PTQTMimplants for the treatment of incontinent patients due to internal anal sphincter dysfunction [J].
de la Portilla, F. ;
Fernandez, A. ;
Leon, E. ;
Rada, R. ;
Cisneros, N. ;
Maldonado, V. H. ;
Vega, J. ;
Espinosa, E. .
COLORECTAL DISEASE, 2008, 10 (01) :89-94
[5]   Injectable synthetic calcium hydroxylapatite ceramic microspheres (Coaptite) for passive fecal incontinence [J].
Ganio, E. ;
Marino, F. ;
Giani, I. ;
Luc, A. Realis ;
Clerico, G. ;
Novelli, E. ;
Trompetto, M. .
TECHNIQUES IN COLOPROCTOLOGY, 2008, 12 (02) :99-102
[6]   Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial [J].
Graf, Wilhelm ;
Mellgren, Anders ;
Matzel, Klaus E. ;
Hull, Tracy ;
Johansson, Claes ;
Bernstein, Mitch .
LANCET, 2011, 377 (9770) :997-1003
[7]   Long-term evaluation of bulking agents for the treatment of fecal incontinence: clinical outcomes and ultrasound evidence [J].
Guerra, F. ;
La Torre, M. ;
Giuliani, G. ;
Coletta, D. ;
Amore Bonapasta, S. ;
Velluti, F. ;
La Torre, F. .
TECHNIQUES IN COLOPROCTOLOGY, 2015, 19 (01) :23-27
[8]   Systematic review of perianal implants in the treatment of faecal incontinence [J].
Hussain, Z. I. ;
Lim, M. ;
Stojkovic, S. G. .
BRITISH JOURNAL OF SURGERY, 2011, 98 (11) :1526-1536
[9]  
Kumar D, 1998, BRIT J SURG, V85, P978
[10]   Long-term efficacy of dextranomer in stabilized hyaluronic acid (NASHA/Dx) for treatment of faecal incontinence [J].
La Torre, F. ;
de la Portilla, F. .
COLORECTAL DISEASE, 2013, 15 (05) :569-574